Trials / Sponsors / Nathan Pennell, MD, PhD
Nathan Pennell, MD, PhD
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC Stage IIIA Non-Small Cell Lung Cancer | Phase 1 | 2017-05-19 |
| Completed | Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung C Lung Cancer | Phase 2 | 2009-09-01 |
| Completed | Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cance Lung Cancer | Phase 1 / Phase 2 | 2005-10-01 |